The global ocular adhesives and sealants market size is expected to reach USD 319.9 million by 2030, expanding at a CAGR of 8.28% from 2022 to 2030, according to a new report by Grand View Research, Inc. The market is expanding as a result of the rising ophthalmic surgical procedures and technological advancements. The demand for better surgical treatment is increasing, which is helping the market for ocular sealants grow.
Approximately 2,000 American workers suffer work-related eye injuries each day, according to the National Institute for Occupational Safety and Health (NIOSH). These injuries require medical attention. Approximately 1.3 million Americans over the age of 40 are totally blind, approximately 4.2 Americans over the age of 40 are visually impaired, and more than 150 million Americans require corrective lenses for refractive problems, according to statistics provided by the Centers for Disease Control and Prevention (CDC) and the American Academy of Ophthalmology (AAO). Around 3% of emergency visits to ophthalmic clinics or hospitals are due to high-frequency eye injuries leading to eye damage.
As previously indicated, suturing has a number of disadvantages, including endophthalmitis, tissue damage, and astigmatism. When compared to other wound closure options, suturing is not the best procedure because it also calls for a skilled surgeon. Ocular adhesives, which are intended to address the drawbacks of sutures, are one alternative. Ophthalmic surgeons are preferring suture-less surgery to avoid these issues. Contrary to traditional suturing, the use of adhesive has been demonstrated to reduce the likelihood of post-operative wound infection. Ocular sealants have also improved eye vision, shortened recovery times, and reduced the frequency of enucleation. These ocular sealants are used during wound reconstruction to improve the patient's post-operative state while preserving the wound's integrity. Ocular sealants and adhesives are employed in a variety of indications because each type has distinct advantages and disadvantages.
Request a free sample copy or view report summary: Ocular Adhesives And Sealants Market Report
The natural type segment held the largest revenue share in 2021 owing to its widespread applications in medical practice. Among the natural sealants and adhesives, fibrin sealants held the largest revenue share in 2021
The tissue engineering application segment held the largest share in 2021 due to the rising geriatric population, increasing ophthalmic disorders, and rising inclination towards early disease diagnosis and treatment
The ophthalmic clinics end-use segment led the market in 2021 due to the rising cases of ophthalmic surgeries including cataract and refractive surgeries in specialized ophthalmic clinics
North America emerged as the leading market in 2021 owing to factors such as rising prevalence of ocular disorders, presence of well-built infrastructure, availability of skilled ophthalmic surgeons, and presence of key players
Grand View Research has segmented the global ocular adhesives and sealants market on the basis of type, application, end-use, and region:
Ocular Adhesives And Sealants Type Outlook (Revenue, USD Million, 2017 - 2030)
Synthetic
Urethane-based Adhesives
Polyethylene Glycol Adhesives
Cyanoacrylates
Natural
Fibrin Adhesives
Collagen-based Adhesives
Gelatin-based Adhesives
Others
Ocular Adhesives And Sealants Application Outlook (Revenue, USD Million, 2017 - 2030)
Tissue Engineering
Conjunctival Surgery
Refractive Surgery
Vitreo-retinal Surgery
Corneal Surgery
Ocular Adhesives And Sealants End-use Outlook (Revenue, USD Million, 2017 - 2030)
Hospitals
Ophthalmic Clinics
Ambulatory Surgical Centers
Ocular Adhesives And Sealants Regional Outlook (Revenue, USD Million, 2017 - 2030)
North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Asia Pacific
Japan
China
India
Australia
South Korea
Latin America
Brazil
Mexico
Argentina
Colombia
MEA
South Africa
Saudi Arabia
UAE
List of Key Players of Ocular Adhesives And Sealants Market
Ocular Therapeutix, Inc.
Reliance Life-Sciences
Baxter
Medtronic PLC
B. Braun Melsungen AG
"The quality of research they have done for us has been excellent..."